| The mechanism of action of the controversial drug; aducanumab and the story behind its speedy approval A Zainab JPMA. The Journal of the Pakistan Medical Association 72 (5), 1019, 2022 | 1 | 2022 |
| Abstract Number‐165: Are Smaller Stentrievers the Answer for Achieving Procedural Success in Distal Vessel Occlusions (DiVO)? A Zainab, N Dharwadkar, S Desai, WG Tekle Stroke: Vascular and Interventional Neurology 3, e12592, 2023 | | 2023 |
| Abstract Number‐159: Intubation for Patients Undergoing Mechanical Thrombectomy of DiVOs is Associated with Increased Symptomatic ICH A Zainab, S Desai, H Saei, WG Tekle Stroke: Vascular and Interventional Neurology 3, e12586, 2023 | | 2023 |
| Consumption of Cannabis: A Risk Factor or a Therapeutic Agent for Patients with Schizophrenia A Zainab, D Shabbir, K Waqar, A Mehmood Cognizance of Schizophrenia:: A Profound Insight into the Psyche, 249-269, 2023 | | 2023 |
| Iron and Subarachnoid Hemorrhage A Zainab, A Hamid Brain-Iron Cross Talk, 211-227, 2022 | | 2022 |
| The tale and trials of Efgartigimod: a newly FDA approved drug for the 3 treatment of Myasthenia gravis 4 K Waqar, A Zainab JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION 72 (11), 2366-2367, 2022 | | 2022 |
| Role of the Gut Microbiome in the Pathophysiology and Treatment of Type 2 Diabetes Mellitus: A Mini Review A Zainab, A Mago, A Mehmood, M Riad, SR Sonavane National Journal of Health Sciences 6 (2), 75-79, 2021 | | 2021 |
| IFMSA Policy Proposal [Non-Communicable Diseases] SKM India, MPI Poland, OHMSI Egypt, YXA Australia, AZI Pakistan, ... | | |
| IFMSA Policy Document Antimicrobial Resistance S Khan, M India, A Zainab, I Pakistan | | |
